Related Experiment Video
Updated: May 8, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Glaucoma: genes, phenotypes, and new directions for therapy
1Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
The Journal of Clinical Investigation
|September 3, 2010
Summary
This review explores human genetics and genomics to understand glaucoma, a major cause of blindness. Research highlights potential gene-based and cellular therapies for this optic nerve disease.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Glaucoma is a leading global cause of irreversible blindness.
- Characterized by progressive optic nerve damage, often linked to elevated intraocular pressure.
- Current understanding of glaucoma's molecular basis is limited, and existing treatments are not curative.
Purpose of the Study:
- To review human genetics and genomic studies on glaucoma.
- To elucidate the complex inheritance patterns of glaucoma-associated genes.
- To explore the potential of novel gene-based and cellular therapies.
Main Methods:
- Literature review of human genetics and genomic research in glaucoma.
- Analysis of studies identifying glaucoma susceptibility genes.
- Examination of emerging gene and cell therapy strategies.
Main Results:
- Human genetics and genomic approaches have identified multiple genes involved in glaucoma.
- These studies reveal the complex genetic architecture underlying glaucoma.
- Significant progress has been made in understanding gene function and disease mechanisms.
Conclusions:
- Genetic research provides critical insights into glaucoma pathogenesis.
- Gene-based and cellular therapies offer promising future treatment avenues.
- Further research is needed to translate genetic findings into effective clinical interventions.
Related Concept Videos
01:11Genetic Lingo
Overview
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...